173 Participants Needed

Heart Matters Program for Cardiovascular Disease

(Co-LEARN Trial)

Recruiting at 10 trial locations
GD
KW
Overseen ByKristen Witkemper, MPH
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of North Carolina, Chapel Hill
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

Trial Summary

Do I need to stop my current medications to join the trial?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the Heart Matters Program treatment for cardiovascular disease?

The effectiveness of the Heart Matters Program for cardiovascular disease may be supported by similar programs that focus on outcomes management, which have shown improved patient outcomes in heart failure and coronary artery disease by regularly measuring and providing feedback on patient progress.12345

What makes the Heart Matters Program treatment unique for cardiovascular disease?

The Heart Matters Program is unique because it focuses on a multidisciplinary, behavior-oriented approach that includes lifestyle changes like diet and exercise, similar to the Heart Smart Program, which has shown positive results in reducing cardiovascular risk factors in families. This program is adaptable to clinical practice and emphasizes active communication between patients and health professionals to improve health outcomes.678910

What is the purpose of this trial?

The goal of this non-randomized, propensity-matched-controlled study is to assess the effectiveness of the Heart Matters evidence-based program -- previously evaluated for feasibility and efficacy in NCT02707432 -- in improving cardiovascular health outcomes (change in systolic and diastolic blood pressure, primary outcomes) when implemented by community-based facilitators.

Research Team

GD

Gaurav Dave, MBBS, DrPH

Principal Investigator

University of North Carolina, Chapel Hill

Eligibility Criteria

This trial is for individuals with cardiovascular disease living in rural areas. Participants should be interested in improving their heart health and willing to work with community-based facilitators.

Inclusion Criteria

Identify as Black or African American
Reside in rural, eastern North Carolina
I have a risk factor for heart disease like pre-diabetes, high blood pressure, obesity, or a family history of it.

Exclusion Criteria

I am able to understand and give informed consent.
I have heart problems that are currently not stable.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive the Heart Matters intervention delivered by community-based facilitators

12 months
Regular visits as per intervention schedule

Follow-up

Participants are monitored for safety and effectiveness after treatment

6 months
Follow-up assessments at 6 and 12 months

Treatment Details

Interventions

  • Heart Matters
Trial Overview The study tests the 'Heart Matters' program, which aims to improve blood pressure (both systolic and diastolic) as primary outcomes. It's a non-randomized study comparing participants who receive the program against those who do not.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention GroupExperimental Treatment1 Intervention
This group will receive the Heart Matters intervention, delivered by community-based facilitators. All participants consenting to the present study will be assigned to this arm.
Group II: Propensity-matched Control Group (Retrospective)Active Control1 Intervention
This group received the Heart Matters intervention, delivered by researchers, under NCT02707432.

Heart Matters is already approved in United States for the following indications:

🇺🇸
Approved in United States as Heart Matters Program for:
  • Cardiovascular health improvement
  • Hypertension management

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of North Carolina, Chapel Hill

Lead Sponsor

Trials
1,588
Recruited
4,364,000+

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator

Trials
3,987
Recruited
47,860,000+

James McFarlin Community Development, Inc.

Collaborator

Trials
2
Recruited
350+

Opportunities Industrialization Center, Inc.

Collaborator

Trials
1
Recruited
210+

Project Momentum, Inc.

Industry Sponsor

Trials
2
Recruited
350+

James McFarlin Community Development, Inc.

Collaborator

Trials
2
Recruited
350+

Findings from Research

The International Consortium for Health Outcomes Measurement (ICHOM) has established a consensus standard set of 13 outcome measures for tracking and improving care in patients with coronary artery disease (CAD), which includes both immediate and long-term health outcomes.
These measures are designed to be applicable to all CAD patients, including those with acute myocardial infarction and asymptomatic CAD, and aim to enhance the quality of care by providing relevant data for physicians and hospitals to improve patient outcomes.
Standardized Outcome Measurement for Patients With Coronary Artery Disease: Consensus From the International Consortium for Health Outcomes Measurement (ICHOM).McNamara, RL., Spatz, ES., Kelley, TA., et al.[2022]
St. Luke's Episcopal Hospital has successfully improved patient outcomes in interventional cardiology over a decade by implementing an outcomes management approach.
The article details the specific processes used and the positive results achieved, highlighting the effectiveness of structured management in enhancing patient care.
Challenge of managing interventional cardiology patients over a decade.Scroggins, NM., Houston, S., Clark, M., et al.[2019]
A new department is being established to focus on improving patient outcomes in cardiovascular care by addressing key issues like definitions, measurement, and data sources.
The initiative aims to foster discussion and research that will enhance understanding and practices related to nurse-sensitive and multidisciplinary outcomes in patient care.
Outcomes measurement.Deaton, C.[2019]

References

Standardized Outcome Measurement for Patients With Coronary Artery Disease: Consensus From the International Consortium for Health Outcomes Measurement (ICHOM). [2022]
Challenge of managing interventional cardiology patients over a decade. [2019]
Outcomes measurement. [2019]
Kaiser Permanente reports improved outcomes for heart failure patients. [2007]
Linking outcomes management and practice improvement. The link between outcomes management and JCAHO functions. [2019]
[Implementation design of the HEARTS healthy-lifestyle counselling module at the first level of care in MexicoDelineamento da implementação do módulo de hábitos e estilos de vida saudáveis da Iniciativa HEARTS na atenção primária do México]. [2022]
Health promotion model for "Heart Smart": the medical school, university, and community. [2007]
Cardiovascular intervention for high-risk families: the Heart Smart Program. [2019]
Implementation of Modified Cardiovascular Health Awareness Program for Canadian Adults on a Waiting List for a Family Physician. [2021]
10.United Statespubmed.ncbi.nlm.nih.gov
From heart health promotion to chronic disease prevention: contributions of the Canadian Heart Health Initiative. [2018]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security